Leukotriene B4 receptor knockdown affects PI3K/AKT/mTOR signaling and apoptotic responses in colorectal cancer
Related Experiment Video
Updated: Jul 5, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Cui Tang1, Aili Wang2, YanLin Zhao1
1Department of Radiology, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, China.
Abstract:
Colorectal cancer (CRC) presents a landscape of intricate molecular dynamics. In this study, we focused on the role of the leukotriene B4 receptor (LTB4R) in CRC, exploring its significance in the disease's progression and potential therapeutic approaches. Using bioinformatics analysis of the GSE164191 and the Cancer Genome Atlas-colorectal adenocarcinoma (TCGA-COAD) datasets, we identified LTB4R as a hub gene influencing CRC prognosis. Subsequently, we examined the relationship between LTB4R expression, apoptosis, and the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway through cellular and mice experiments. Our findings revealed that LTB4R is highly expressed in CRC samples and is pivotal for determining prognosis. In vitro experiments demonstrated that silencing LTB4R significantly impeded CRC cell viability, migration, invasion, and colony formation. Correspondingly, in vivo tests indicated that LTB4R knockdown led to markedly slower tumor growth in mice models. Further in-depth investigation revealed that LTB4R knockdown significantly amplified the apoptosis in CRC cells and upregulated the expression of apoptosis-related proteins, such as caspase-3 and caspase-9, while diminishing p53 expression. Interestingly, silencing LTB4R also resulted in a significant downregulation of the PI3K/AKT/mTOR signaling pathway. Moreover, pretreatment with the PI3K activator 740Y-P only partially attenuated the effects of LTB4R knockdown on CRC cell behavior, emphasizing LTB4R's dominant influence in CRC cell dynamics and signaling pathways. LTB4R stands out as a critical factor in CRC progression, profoundly affecting cellular behavior, apoptotic responses, and the PI3K/AKT/mTOR signaling pathway. These findings not only shed light on LTB4R's role in CRC but also establish it as a potential diagnostic biomarker and a promising target for therapeutic intervention.
Insights
Leukotriene B4 receptor (LTB4R) is highly expressed in colorectal cancer (CRC), driving tumor growth and progression. Targeting LTB4R inhibits CRC cell viability and tumor growth, offering a promising therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Colorectal cancer (CRC) exhibits complex molecular mechanisms influencing its progression.
- The role of leukotriene B4 receptor (LTB4R) in CRC pathogenesis requires further elucidation.
- Identifying key molecular drivers is crucial for developing effective CRC therapies.
Purpose of the Study:
- To investigate the role of LTB4R in colorectal cancer progression and prognosis.
- To explore the relationship between LTB4R, apoptosis, and the PI3K/AKT/mTOR pathway in CRC.
- To assess LTB4R as a potential therapeutic target for CRC.
Main Methods:
- Bioinformatic analysis of TCGA-COAD and GSE164191 datasets to identify LTB4R as a hub gene.
- In vitro experiments involving LTB4R silencing in CRC cells to assess proliferation, migration, and invasion.
- In vivo studies using mice models to evaluate the impact of LTB4R knockdown on tumor growth.
- Analysis of apoptosis-related proteins and the PI3K/AKT/mTOR pathway.
Main Results:
- LTB4R is significantly overexpressed in CRC tissues and correlates with poor prognosis.
- Silencing LTB4R inhibits CRC cell viability, migration, invasion, and colony formation.
- LTB4R knockdown reduces tumor growth in vivo and enhances apoptosis by upregulating caspase-3/9 and downregulating p53.
- LTB4R silencing leads to the downregulation of the PI3K/AKT/mTOR pathway.
Conclusions:
- LTB4R is a critical driver of colorectal cancer progression, influencing cellular behavior and apoptosis.
- LTB4R plays a significant role in regulating the PI3K/AKT/mTOR signaling pathway in CRC.
- LTB4R represents a promising diagnostic biomarker and a potential therapeutic target for colorectal cancer treatment.
More Related Videos
13:45Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
Published on: December 23, 2010
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
Regulation of Angiogenesis and Blood Supply
Targeted Cancer Therapies
There are several types of targeted therapies against...